Progress in antisense technology: The end of the beginning
- 1 January 2000
- book chapter
- Published by Elsevier
- Vol. 313, 3-45
- https://doi.org/10.1016/s0076-6879(00)13003-4
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- Evaluation of the Toxicity of ISIS 2302, a Phosphorothioate Oligonucleotide, in a 4-Week Study in CD-1 MiceAntisense and Nucleic Acid Drug Development, 1997
- DNA antisense therapy for asthma in an animal modelNature, 1997
- Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley ratsToxicology, 1997
- Oligonucleotide duplex stability controlled by the 7-substituents of 7-deazaguanine basesBioorganic & Medicinal Chemistry Letters, 1995
- Inhibition of Interferon-γ-Induced Intercellular Adhesion Molecule-1 Expression on Human Keratinocytes by Phosphorothioate Antisense Oligodeomynucleotides Is the Consequence of Antisense-Specific and Antisense-Non-Specific EffectsJournal of Investigative Dermatology, 1995
- Suppression of Neointimal Smooth Muscle Cell Accumulation in Vivo by Antisense cdc2 and cdk2 Oligonucleotides in Rat Carotid ArteryBiochemical and Biophysical Research Communications, 1994
- Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virusLife Sciences, 1994
- Antisense oligonucleotides made of 2'‐O‐alkylRNA: their properties and applications in RNA biochemistryFEBS Letters, 1993
- Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense OligodeoxynucleotidesScience, 1993
- Extension of the Life-Span of Human Endothelial Cells by an Interleukin-1αAntisense OligomerScience, 1990